U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543419) titled 'Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe HS Within the Italian Population' on Nov. 14, 2025.
Brief Summary: The aim of this study is to generate real-world evidence to fill knowledge gaps regarding the response to secukinumab in patients with moderate to severe HS, its treatment patterns, the clinical characteristics of patients on secukinumab, healthcare resource utilization and the economic impact of HS in Italy.
Study Start Date: Dec. 17, 2025
Study Type: OBSERVATIONAL
Condition:
Hidradenitis Suppurativa
Recruit...